Twenty-two cutaneous primary melanomas in a patient with high genetic predisposition to melanoma receiving levodopa therapy for Parkinson's disease. [electronic resource]
- Pigment cell & melanoma research Dec 2009
- 851-3 p. digital
Publication Type: Case Reports; Letter
1755-148X
10.1111/j.1755-148X.2009.00624.x doi
DNA Mutational Analysis Genetic Predisposition to Disease Humans Levodopa--adverse effects Male Melanoma--drug therapy Middle Aged Parkinson Disease--drug therapy Skin Neoplasms--drug therapy Ultraviolet Rays--adverse effects